Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance.
Carretero FJ, Del Campo AB, Flores-Martín JF, Mendez R, García-Lopez C, Cozar JM, Adams V, Ward S, Cabrera T, Ruiz-Cabello F, Garrido F, Aptsiauri N.
Carretero FJ, et al. Among authors: del campo ab.
Cancer Immunol Immunother. 2016 Jan;65(1):47-59. doi: 10.1007/s00262-015-1774-5. Epub 2015 Nov 26.
Cancer Immunol Immunother. 2016.
PMID: 26611618
Free PMC article.